Qure Bio

Shanghai, China Founded: 2017 • Age: 9 yrs
Antibody drugs are developed to treat multiple diseases.

About Qure Bio

Qure Bio is a company based in Shanghai (China) founded in 2017 by Xiangdong Qu.. Qure Bio has raised $14 million across 1 funding round from investors including Efung Capital. Qure Bio operates in a competitive market with competitors including Moderna, BeiGene, Incyte, Horizon Therapeutics and Forge Biologics, among others.

  • Headquarter Shanghai, China
  • Founders Xiangdong Qu
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $14 M (USD)

    in 1 rounds

  • Latest Funding Round
    $14 M (USD), Series C

    Jun 06, 2025

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Qure Bio

Qure Bio has successfully raised a total of $14M through 1 strategic funding round. The most recent funding activity was a Series C round of $14 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series C — $14.0M
  • First Round

    (06 Jun 2025)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2025 Amount Series C - Qure Bio Valuation Efung Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Qure Bio

Qure Bio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Efung Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Efung Capital is focused on global biopharmaceutical investments.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Qure Bio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Qure Bio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Qure Bio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Qure Bio

Qure Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Incyte, Horizon Therapeutics and Forge Biologics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
mRNA-based therapeutics for diseases including cancer and infections are developed.
domain founded_year HQ Location
Targeted and immune-oncology drugs for cancer treatment are developed.
domain founded_year HQ Location
Small molecules are developed for cancer and skin disease treatments.
domain founded_year HQ Location
Developer of drugs for treating rare and autoimmune diseases
domain founded_year HQ Location
Gene therapies for rare diseases are developed to treat patients.
domain founded_year HQ Location
Therapeutic antibodies for cancer and other diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Qure Bio

When was Qure Bio founded?

Qure Bio was founded in 2017 and raised its 1st funding round 8 years after it was founded.

Where is Qure Bio located?

Qure Bio is headquartered in Shanghai, China.

Is Qure Bio a funded company?

Qure Bio is a funded company, having raised a total of $14M across 1 funding round to date. The company's 1st funding round was a Series C of $14M, raised on Jun 06, 2025.

What does Qure Bio do?

Qure Bio was founded in 2017 in Shanghai, China, within the biotechnology sector. Antibody therapeutics are created using specialized platforms, including hybridoma humanization, phage display, and engineering technologies. Focus is placed on a pipeline targeting intractable cancers, autoimmune disorders, and metabolic conditions like diabetes and hyperlipidemia. Operations center on advancing these treatments through research and development in the region.

Who are the top competitors of Qure Bio?

Qure Bio's top competitors include Moderna, argenx and BeiGene.

Who are Qure Bio's investors?

Qure Bio has 1 investor. Key investors include Efung Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available